Castle Biosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $87,002 | $72,974 | $66,120 | $61,493 |
Gross Profit | 69,772 | 56,395 | 51,026 | 50,174 |
EBITDA | 8,359 | -2,131 | -2,434 | -3,697 |
EBIT | 5,011 | -5,471 | -5,658 | -6,871 |
Net Income | 8,920 | -2,534 | -2,580 | -6,905 |
Net Change In Cash | 87,002 | 72,974 | 66,120 | 61,493 |
Free Cash Flow | 18,769 | -15,987 | 20,285 | 2,557 |
Cash | 85,572 | 82,949 | 98,841 | 91,223 |
Basic Shares | 28,738 | 27,485 | 27,030 | 26,834 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $219,788 | $137,039 | $94,085 | $62,649 |
Gross Profit | 164,234 | 105,030 | 78,263 | 52,964 |
EBITDA | -55,647 | -76,631 | -36,604 | -5,697 |
EBIT | -67,977 | -87,174 | -40,011 | -6,169 |
Net Income | -57,466 | -67,138 | -31,292 | -10,284 |
Net Change In Cash | 219,788 | 137,039 | 94,085 | 62,649 |
Free Cash Flow | -13,756 | -47,287 | -22,466 | 5,114 |
Cash | 98,841 | 122,948 | 329,633 | 409,852 |
Basic Shares | 26,802 | 26,054 | 25,137 | 18,929 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | $0.31 |
2024-03-31 | -$0.09 |
2023-12-31 | -$0.10 |
2023-09-30 | -$0.26 |
